Carbidopa, Levodopa And Entacapone recalls

Carbidopa, Levodopa And Entacapone products have been recalled 1 time, most recently on 22 Oct 2025. The recalling company is usually Rising Pharma Holding. The most common reason is packaging defects.

Total recalls1since 2025

Last 12 months1reported

Class I00% of total

Ongoing1latest 22 Oct 2025

Recalls per month, last 24 months

click a bar for that month

0Nov '24 0 0 0Feb 0 0 0May 0 0 0Aug 0 1 0Nov 0 0 0Feb 0 0 0May 0 0 0Aug 0 0

Severity split

Class I 0 0%Class II 1 100%Class III 0 0%

Why carbidopa, levodopa and entacapone is recalled

Packaging Defects1100%

Companies

Rising Pharma Holding1100%

By year

20251100%

Ongoing carbidopa, levodopa and entacapone recalls

1 active

Reported	Class	Recall	Company	Reason	Where
22 Oct 2025Drug	CLASS II	Carbidopa, Levodopa, Entacapone Tablets, 25 mg/100 mg/200 mg recalledCarbidopa, Levodopa And Entacapone	Rising Pharma Holding	Packaging Defects	Nationwide

All carbidopa, levodopa and entacapone recalls, newest first

1 total

Reported	Class	Recall	Company	Reason	Where
22 Oct 2025Drug	CLASS II	Carbidopa, Levodopa, Entacapone Tablets, 25 mg/100 mg/200 mg recalledCarbidopa, Levodopa And Entacapone	Rising Pharma Holding	Packaging Defects	Nationwide

About this list

Records come from FDA enforcement reports and USDA FSIS notices, grouped by normalised name. A company operating under several names may appear more than once.